The primary examination performed from a blood sample to diagnose celiac disease and monitor its treatment is determining the presence of tissue transglutaminase antibodies. Celiac disease is a condition in which gluten contained in cereal products causes damage to the lining of the small intestine. The symptoms of celiac disease can be very mild, almost invisible, or very severe. The most effective method to diagnose celiac disease is enteroscopy, during which a biopsy is collected to detect the mucosal damage to the small intestine caused by celiac disease. Antibody tests from a blood sample are effective, as they are simple to perform. The results that they provide make it easier to select which patients should undergo enteroscopy if celiac disease is suspected. Antibody tests are also useful for assessing the success of the treatment. The celiac disease test is performed on a blood sample. The test does not require fasting or sampling in the morning. Please note that Fimlab is not responsible for interpretation of the results. Abbreviation: S -tTGAbA Examination code: 1885 Reference values: negative below 7 kU/l, limit value 7–10 kU/l, positive above 10 kU/l
Lyhenne: (S -tTGAbA)
Tutkimusnumero: 1885